| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.007 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0074 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |